Cronos weekly forecast: Downside risk persists with technicals pointing to a continued corrective phase

Cronos weekly forecast: Downside risk persists with technicals pointing to a continued corrective phase
Cronos slips 6.69% this week

Cronos (CRO) is trading near $0.05 after nearly a 7% drop over the last week, as recent selling pressure stretches market conditions into oversold territory. With support now coming into focus, traders will be watching for signs of exhaustion or a potential stabilization as the new week begins.

CRO price prediction
24H -2.77%
$0.05026
48H -3.71%
$0.04977
7D -7.1%
$0.04802
1M -21.59%
$0.04053
3M -61.87%
$0.01971
6M -70.73%
$0.01513
12M -60.32%
$0.02051
Current price: $0.05169 -0.00002 0.04%
Real-time Data 16:47
Daily range 0.05114 Arrow from to Icon 0.05173
Weekly range 0.05012 Arrow from to Icon 0.05447
Loading...

Highlights

  • Cronos trades at $0.05133 after a 6.69% weekly decline, sitting well below key moving averages.
  • Bearish indicators persist, with the long-term trend negative and a high probability of additional downside ahead.
  • Key levels are $0.05012 support and $0.05447 resistance, with the expected range at $0.04902 to $0.05363 for the coming week.

Buyback and burn activity boosts transparency after fee-driven token removal

Cronos completed its first monthly buyback and burn program after removing 1,791,534.14 CRO—worth about $92,000—on October 30, 2026 (source: TokenPost). According to TechFlow and TokenPost, the mechanism uses revenue from Cronos Ult trading fees and Cronos Launch token issuance fees, which have both contributed to these open-market burns since September 2026. The company plans to disclose the transaction hash for each future buyback as part of its ongoing transparency.

Sustained momentum lower as oversold signals prompt search for exhaustion

On the daily chart, Cronos shows a clear trending structure with a sustained move lower and a firm trend, as reflected by the MACD and ADX both forecasting further downside. Volatility over the past week stands at 8.68%. The CCI is in its oversold zone at -133.88294, suggesting the potential for selling exhaustion, while RSI and Stochastic RSI both remain in neutral zones for now. Key levels to watch are support at $0.05012 and resistance at $0.05447, with the Ichimoku Kijun near-term barrier at $0.05984.

Further downside favored as base case anchors range near key support

Over the coming week, the expected range is $0.04902 to $0.05363. There is a very low probability (less than 20%) of an increase and a very high probability (more than 80%) of further decline. The base case calls for Cronos to remain pressured within this range, anchored to support at $0.05012. A break above $0.05447 would suggest potential for recovery, while a fall below $0.05012 opens the door to additional losses toward the lower end of the projected range.

Parshwa Turakhiya, analyst, sees Cronos trading near $0.05 after a challenging week marked by a sharp 7% drawdown and clear signs of selling exhaustion emerging in the technicals. The first monthly buyback and burn, which removed 1,791,534.14 CRO, adds a positive sentiment layer but has yet to stop the downside momentum, with MACD and ADX still pointing lower. Indicators like the CCI deep in oversold territory hint at potential stabilization, while major support at $0.05012 will be crucial in the days ahead. There is a low probability for a meaningful recovery, and the base case keeps price stuck in a narrow range unless bulls reclaim resistance at $0.05447. "I am watching for signs of exhaustion around support, but until $0.05447 breaks, downside risks remain in play for Cronos this week."

Earlier, analysts noted that Cronos faced persistent downside risk as technical signals and ongoing token unlocks reinforced a bearish outlook. The current analysis strengthens this scenario, with oversold conditions and continued selling pressure suggesting that traders should closely monitor the $0.05012 support for any signs of further breakdown.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.